Trial intelligence / Profile preview

Split-dose crystalline lactulose for colonoscopy preparation

NCT01650870Phase 2Completed

Sponsor
Benaroya Research Institute
Start
Jul 2012
Primary completion
Sep 2012
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of lactulose, sponsored by Benaroya Research Institute. Primary endpoint: Boston Bowel Preparation Scale. Started Jul 2012; status: completed.

02

Drugs

lactulose

Beyond the preview

Go deeper on NCT01650870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01650870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call